Owl Creek Asset Management, L.P. - NRX PHARMACEUTICALS INC ownership

NRX PHARMACEUTICALS INC's ticker is NRXP and the CUSIP is 629444100. A total of 34 filers reported holding NRX PHARMACEUTICALS INC in Q4 2022. The put-call ratio across all filers is 0.18 and the average weighting 0.0%.

Quarter-by-quarter ownership
Owl Creek Asset Management, L.P. ownership history of NRX PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2022$37,000
+23.3%
50,0000.0%0.00%0.0%
Q2 2022$30,000
-75.6%
50,0000.0%0.00%
-80.0%
Q1 2022$123,000
-48.5%
50,0000.0%0.01%
-68.8%
Q4 2021$239,000
-48.5%
50,0000.0%0.02%
-23.8%
Q3 2021$464,000
-86.3%
50,000
-83.3%
0.02%
-86.5%
Q2 2021$3,399,000300,0000.16%
Other shareholders
NRX PHARMACEUTICALS INC shareholders Q4 2022
NameSharesValueWeighting ↓
Texas Capital Bank Wealth Management Services Inc 63,290$41,7140.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 230,700$152,0540.00%
Virtu Financial LLC 46,210$300.00%
United Asset Strategies, Inc. 18,300$12,0620.00%
HBK Sorce Advisory LLC 29,230$19,2660.00%
UBS Group AG 18,611$12,2650.00%
NewEdge Advisors, LLC 2,125$1,4010.00%
OSAIC HOLDINGS, INC. 27,225$17,9330.00%
BANK OF AMERICA CORP /DE/ 30,000$19,7700.00%
WELLS FARGO & COMPANY/MN 5,309$3,5000.00%
View complete list of NRX PHARMACEUTICALS INC shareholders